The role of inflammation in cardiovascular disease

MY Henein, S Vancheri, G Longo… - International journal of …, 2022 - mdpi.com
Atherosclerosis is a chronic inflammatory disease, in which the immune system has a
prominent role in its development and progression. Inflammation-induced endothelial …

Atherosclerosis, an inflammatory disease

A Cagnina, O Chabot, L Davin, M Lempereur… - Revue Medicale de …, 2022 - europepmc.org
Chronic inflammation is recognized as a contributing factor to the development, progression
and complications of atherosclerosis. The inflammatory nature of atherosclerosis has been …

Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions

P Raggi, J Genest, JT Giles, KJ Rayner, G Dwivedi… - Atherosclerosis, 2018 - Elsevier
Abstract Rudolph Virchow (1821–1902) recognized inflammation in histological
preparations of coronary arteries and proposed that inflammation plays a causal role in …

Phenolic compounds exerting lipid-regulatory, anti-inflammatory and epigenetic effects as complementary treatments in cardiovascular diseases

L Toma, GM Sanda, LS Niculescu, M Deleanu… - Biomolecules, 2020 - mdpi.com
Atherosclerosis is the main process behind cardiovascular diseases (CVD), maladies which
continue to be responsible for up to 70% of death worldwide. Despite the ongoing …

Mechanisms and therapy of atherosclerosis and its clinical complications

M Barton - Current Opinion in Pharmacology, 2013 - Elsevier
In 1913, exactly 100 years ago, Nikolai Nikolaevich Anichkov (1885–1964) and Semen
Sergeevich Chalatov (1884–1951) discovered in St. Petersburg, Russia, that atherosclerosis …

Inflammatory cytokines and atherosclerotic plaque progression. Therapeutic implications

AV Sterpetti - Current Atherosclerosis Reports, 2020 - Springer
Abstract Purpose of the Review Inflammatory cytokines play a major role in atherosclerotic
plaque progression. This review summarizes the rationale for personalized anti …

Prevention of cardiovascular diseases with anti-inflammatory and anti-oxidant nutraceuticals and herbal products: an overview of pre-clinical and clinical studies

S Jain, HS Buttar, M Chintameneni… - Recent patents on …, 2018 - ingentaconnect.com
Background: Inflammation-induced endothelial abnormalities, dietary habits, and tobacco
smoking are considered to be the primary risk factors for causing atherosclerosis and …

Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events

MJ van Rooy, E Pretorius - Current Medicinal Chemistry, 2014 - ingentaconnect.com
Atherosclerosis is a widespread disease of the arterial system that is generated by injury to
the vasculature due to hypercholesterolemia, hypertension and inflammatory diseases. In …

BHUx: a patent polyherbal formulation to prevent atherosclerosis

YB Tripathi, BK Singh, RS Pandey… - Evidence‐Based …, 2005 - Wiley Online Library
Ayurvedic medicine is a time‐tested system of medicine which has been in clinical use for
centuries in India. Being a time‐tested system, it has an edge over other existing systems of …

Anti-inflammatory drugs and atherosclerosis

SP Moubayed, TM Heinonen… - Current opinion in …, 2007 - journals.lww.com
Due to the contributory inflammatory pathways in atherosclerosis, the properties of existing
and novel anti-inflammatory agents are being carefully and actively evaluated in …